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Background: Previous studies demonstrated that selenite induced cancer-cell apoptosis through multiple
mechanisms; however, effects of selenite on microtubules in leukemic cells have not been demonstrated.
Methods: The toxic effect of selenite on leukemic HL60 cells was performed with cell counting kit 8. Selenite
effects on cell cycle distribution and apoptosis induction were determined by flow cytometry. The contents of
cyclin B1, Mcl-1, AIF, cytochrome C, insoluble and soluble tubulins were detected with western blotting.
Microtubules were visualized with indirect immunofluorescence microscopy. The interaction between CDK1 and
Mcl-1 was assessed with immunoprecipitation. Decreasing Mcl-1 and cyclin B1 expression were carried out through
siRNA interference. The alterations of Mcl-1 and cyclin B1 in animal model were detected with either
immunohistochemical staining or western blotting. In situ detection of apoptotic ratio was performed with TUNEL
assay.
Results: Our current results showed that selenite inhibited the growth of HL60 cells and induced
mitochondrial-related apoptosis. Furthermore, we found that microtubule assembly in HL60 cells was altered, those
cells were arrested at G2/M phase, and Cyclin B1 was up-regulated and interacted with CDK1, which led to
down-regulation of the anti-apoptotic protein Mcl-1. Finally, in vivo experiments confirmed the in vitro microtubule
disruption effect and alterations in Cyclin B1 and Mcl-1 levels by selenite.
Conclusions: Taken together, the results from our study indicate that microtubules are novel targets of selenite in
leukemic HL60 cells.
Keywords: Sodium selenite, Apoptosis, Microtubule, Cell cycleIntroduction
Microtubules have important roles in many cell behaviors
such as cell division, organelle positioning, vesicular trans-
port and cell-shape determination [1-3]. Previous studies
have showed that microtubule dynamics are necessary for
these functions in vivo [2,4-6]. Therefore, chemicals affect-
ing microtubule dynamics often impact these functions
in vivo. On that basis, many anti-tumor agents have been
developed for their effects on microtubule dynamics and
cell-cycle distribution [7-12].
Selenium (Se) is an essential trace element [13], and ap-
propriate selenium intake is necessary for the body to
synthesize selenoproteins. Some researchers have shown
that selenite concentrations that are within the nutritional* Correspondence: caiminxu@yahoo.com.cn
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reproduction in any medium, provided the orrange inhibit tumor formation by acting on antioxidants
and in the inhibition of DNA adduct formation, the pro-
motion of cell cycle progression and DNA repair [14-16].
However, super-nutritional levels of selenite induce endo-
plasmic reticulum stress, mitochondrial-related apoptosis,
DNA strand breaks and cell-cycle arrest [15-19]. There-
fore, many molecules, such as Akt, GADD153, P53, ERK,
P38, Bad, Bim and Bax [20-24], have been reported to be
involved in high-dose selenite-induced apoptosis. Add-
itionally, super-nutritional selenite intake has been shown
to be toxic to drug-resistant cancer cells and effective on
tumor xenografts, which suggests that selenite has poten-
tial therapeutic effects [23-25].
In an in-depth study of selenium, selenite was reported
to have strong inhibitory effects on sulfhydryl-containing
proteins [15] such as tubulins, which composed microtu-
bules [26,27], but the effects of selenite on microtubules. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mics study, proteins linked to microtubule dynamics were
thought to have roles in selenite-triggered apoptosis [28].
Therefore, our study aimed to investigate the role of selen-
ite in microtubule assembly and induction of apoptosis.
Results
Sodium selenite inhibits growth and induces apoptosis in
HL60 cells
We first observed that selenite inhibited growth of HL60
cells. After cells were exposed to differing concentrations
of sodium selenite, cell viability was assessed using CCK-8
kits. Figure 1A showed that 20 μM selenite significantly
reduced cell viability after 24 h. To further investigate if
growth inhibition was caused by apoptosis, the cells
were stained with Annexin V-FITC/PI. Flow cytometry
analysis proved that typical apoptosis was elicited by
20 μM selenite (Figure 1B). To identify which pathwayFigure 1 Sodium selenite-induced, cell-proliferation inhibition and ap
proliferation of HL60 leukemia cells. Cells were treated with varying concen
CCK-8 kits. Mean values of three repetitions were displayed, and *P < 0.05,
apoptosis in HL60 leukemia cells. Cells were collected after exposure to var
FITC/PI, and the apoptotic ratio was detected using flow cytometry. The re
compared with untreated cells. (C) Selenite induced the release of cytochro
were treated with 20 μM of selenite for the indicated times, fractions of mi
AIF contents of each fraction were detected by western blotting. This expe
induced nucleus fragmentation of HL60 cells at 24 h, which was detected
10 μm. This experiment was repeated at least 3 timesparticipated in selenite-induced apoptosis, we extracted
the mitochondrial fraction of HL60 cells after they were
exposed to selenite and discovered that cytochrome C
and AIF were released (Figure 1C), which suggested
that a mitochondrial-related apoptotic pathway was uti-
lized. Furthermore, we observed nuclear fragmentation
after staining with DAPI (Figure 1D).
Sodium selenite alters microtubule assembly in cultured
leukemia cells
We then determined the mechanisms by which selenite
inhibited the growth of HL60 cells. Tubulin exists in
mainly two forms: soluble heterodimers that are composed
of β- and α-tubulin or insoluble polymers. To detect
whether selenite induced microtubule depolymerization,
we extracted insoluble and soluble tubulin and discovered
that 20 μM selenite destroyed microtubules. Furthermore,
we observed a significant decrease of insoluble tubulin,optosis in cultured HL60 cells. (A) Sodium selenite inhibited
trations of selenite for 24 h, and cell viability was detected using
when compared with untreated cells. (B) Sodium selenite induced
ying concentrations of selenite for 24 h and labeled with Annexin-V-
sults were representative of three repetitions, and *P < 0.05, when
me C and AIF from the mitochondria to the cytoplasm. After cells
tochondria and cytoplasm were separated, and the cytochrome C and
riment was repeated at least 3 times. (D) Sodium selenite (20 μM)
by immunofluorescence after nuclear staining with DAPI. Scale bar:
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enite exposure (Figure 2A). Indirect immunofluorescence
showed that microtubules presented an integrated, fila-
mentous structure in untreated cells but were dispersive in
response to selenite in HL60 cells (Figure 2B).
Sodium selenite-treated HL60 cells are arrested at G2/M
phase
We aimed to determine if crosstalk between microtubule
disruption and the mitochondrial apoptotic pathway oc-
curred. Because cell cycle arrest could be induced by
microtubule disruption and some cell cycle-related pro-
tein kinases could regulate proteins in the mitochondria,
we analyzed alterations in the cell cycle distribution of
HL60 cells after selenite treatment. Compared with con-
trol, the number of cells was lower at G0/G1 phase and
higher at G2/M phase after selenite treated for 24 h
(Figure 3A). In addition, the protein level of Cyclin B1, a
G2/M phase marker, was remarkably increased. This
was concomitant with a decrease in Mcl-1, which was
located in the mitochondria, in a time-dependent man-
ner (Figure 3B). To illuminate the effect of microtubule
disruption on cell cycle arrest, we employed a combined
treatment of sodium selenite and Taxol (microtubule
stabilizer) in HL60 cells and observed that the alterationFigure 2 Selenite altered microtubule assembly. (A) Sodium selenite (2
selenite, HL60 and Jurkat cells were collected at varying times, and the inso
western blotting. Cells that were treated with Colchicine and Taxol were u
(B) Microtubule depolymerization was detected by indirect immunofluores
indicated times, and microtubules were indirectly labeled with a β-tubulin
10 μm. This experiment was repeated at least 3 timesof Cyclin B1 was abrogated (Figure 3C). As mentioned
above, microtubule reorganization occurred in Jurkat cells;
therefore, we destroyed microtubule reassembly through a
combination of selenite and Colchicine treatments (micro-
tubule depolymerization agent) and found that the altera-
tions in Mcl-1 and Cyclin B1 levels were similar to those
in selenite-treated HL60 cells (Figure 3D).
Cyclin B1 interacted with CDK1 and induced down-
regulation of Mcl-1
All of the above-described observations demonstrated that
microtubule depolymerization was induced by selenite
and took part in the inhibition of HL60 cell cycle progres-
sion. Because Cyclin B1 is necessary in G2/M phase for
the activity of CDK1, which phosphorylates and destabi-
lizes Mcl-1, we confirmed the cellular interactions
between CDK1, Cyclin B1 and Mcl-1 (Figure 4A). Further-
more, either inhibition of Cyclin B1 expression by siRNA
interference or inhibition of CDK1/Cyclin B1 activity by
Roscovitine rescued the down-regulation of Mcl-1
(Figure 4B,C). To further identify the protective role of
Mcl-1, which was consistently altered upon cell cycle ar-
rest, we down-regulated Mcl-1 by siRNA interference and
observed HL60 cell death by cell counting using the CCK-
8 kits (Figure 4D, E). Additionally, silencing Mcl-1 after0 μM) destroyed microtubule integrity. After exposure to 20 μM of
luble and soluble fractions of tubulin were harvested and detected by
sed as positive controls. This experiment was repeated at least 3 times.
cence. The cells were harvested after selenite exposure for the
primary antibody and FITC-conjugated secondary antibody. Scale bar:
Figure 3 The disruption of microtubules, which was induced by selenite, caused cell cycle arrest in HL60 cells. (A) An alteration in the
cell cycle distribution was detected by flow cytometry after cells were exposed to 20 μM of selenite for varying times. The experiment was
repeated three times, the mean value was exhibited, and *P < 0.05, when compared to untreated cells. (B) Cells treated with sodium selenite
(20 μM) showed increased levels of Cyclin B1 and decreased levels of Mcl-1 in a time-dependent manner. After cells were exposed to selenite
(20 μM) for varying times, they were collected, and alterations in Cyclin B1 and Mcl-1 levels were detected by western blotting. This experiment
was repeated at least 3 times. (C) Taxol reversed the change in Cyclin B1 and Mcl-1 levels. Cells were pretreated with Taxol (20 nM) for 1 h before
being exposed to 20 μM sodium selenite. The cells were harvested and alterations in Cyclin B1 and Mcl-1 levels were detected by western
blotting. This experiment was repeated at least 3 times. (D) The disruption of microtubule reorganization caused down-regulation of Mcl-1 and
up-regulation of Cyclin B1 in Jurkat cells. Colchicines (20 nM or 50 nM) were added to cells after selenite exposure at 2 h. After the cells were
treated with selenite (20 μM) for 24 h, they were harvested, and alterations in Cyclin B1 and Mcl-1 levels were detected by western blotting. This
experiment was repeated at least 3 times
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cells (Figure 4F).
Selenite exhibits inhibitory effects on HL60 tumor
xenografts
Finally, we determined the effects of selenite (1.5 mg/kg/
day) on HL60 tumor xenografts. When compared with
the control group, the volume and weight of the tumor
and spleen were reduced in mice exposed to selenite
(Figure 5A, C). Spleen enlargement could be caused by
the infiltration of leukemic cells and it reflected the ma-
lignant degree of tumor cells. CD33 is a known marker
of leukemic cells. Therefore, we detected CD33-positive
cells in the spleen tissue and discovered that CD-33
positive cells decreased after selenite treatment, which
also suggested that selenite had antitumor activity
(Figure 5D). In addition, HE staining result indicated
that selenite caused nucleus pyknosis (Figure 5B). Fur-
thermore, in situ detection of apoptotic tumor cells bythe TUNEL assay showed that there were more apop-
totic cells after selenite treatment (Figure 5G). These
results suggested that selenite had therapeutic effects on
HL60 xenografts. To determine whether microtubules
were depolymerized in this model, we separated soluble
and insoluble tubulin and found that the amount of in-
soluble tubulin was decreased (Figure 5E). Furthermore,
results in Figure 5F showed that selenite up-regulated
Cyclin B1 and down-regulated Mcl-1 levels, which was
consistent with the in vitro findings. Immunohistochem-
ical staining also indicated that Cyclin B1 and Mcl-1 levels
were altered similarly to those in vitro (Figure 5H).
Discussion
Selenium is an essential trace element for animals, and it
has been shown that super-nutritional selenite intake
has anti-tumor activity [14,18,19,27,29]. Several reports
have also proved the anti-tumor effects of selenite
in vivo [24]. However, the effects of selenite on
Figure 4 Cyclin B1 interacted with CDK1 and induced the down-regulation of the anti-apoptotic protein Mcl-1. (A) CDK1 interacted with
Cyclin B1 and Mcl-1. After cells were treated with selenite for 24 h, CDK1 was immunoprecipitated from the cell lysates using a CDK1 antibody,
and the CDK1, Cyclin B1 and Mcl-1 in the precipitates were detected by western blotting. This experiment was repeated at least 3 times. (B)
Inhibiting the expression of Cyclin B1 reversed the decrease of Mcl-1. Cells were transfected with siRNAs targeting Cyclin B1 and treated with
20 μM selenite for 24 h. Cyclin B1 and Mcl-1 were detected by western blotting. This experiment was repeated at least 3 times. (C) Inhibition of
CDK1/Cyclin B1 reversed the down-regulation of Mcl-1. Roscovitine (10μM) was added to cells for 1 h before they were exposed to sodium
selenite (20 μM) for 24 h. The changes of Mcl-1 detected by western blotting. This experiment was repeated at least 3 times. (D) The expression
of Mcl-1 was inhibited by siRNA interference. Cells were transfected with siRNAs targeting Mcl-1 and treated with selenite (20 μM). Mcl-1 levels
were determined by western blotting. This experiment was repeated at least 3 times. (E) Mcl-1 exhibited a protective role in HL60 cells. After Mcl-
1 was knocked down, cell viability was assessed using the CCK-8 kits. The experiment was repeated three times, the mean value was determined,
and *P < 0.05, when compared to untreated cells. (F) Inhibiting the expression of Mcl-1 increased the apoptotic ratio of the cells. Cells were
transfected with siRNAs targeting Mcl-1 and treated with selenite (20 μM) for 24 h. The apoptotic ratio was determined by flow cytometry after
the cells were stained with Annexin-V and PI. This experiment was repeated at least 3 times.
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demonstrated. Our study indicated that microtubules
were a novel target of selenite.
Leynadier D et al. first discovered that selenite could
directly interact with the sulfhydryl groups of β-tubulin
and could inhibit microtubule polymerization in vitro
[26]. To our knowledge, we are the first to discover that
selenite also induces microtubule depolymerization in
HL60 cells and in vivo. However, because microtubules
reorganized in Jurkat but not in HL60 cells, the apop-
totic mechanisms of the two cell lines differed. We
mainly investigated the mechanisms by which selenite
induced apoptosis. Because tumor cells have a strong
ability to replicate themselves and tubulins, which com-
pose spindles, are essential for this process, we speculate
that selenite-induced apoptosis is at least partly
dependent on the effects of selenite on microtubules.
Therefore, the growth inhibitory effect of selenite on
cultured HL60 cells was assessed, and we discovered
that 20 μM of sodium selenite significantly inhibited cell
growth. Furthermore, Annexin V-FITC/PI double stain-
ing assay proved that selenite-induced apoptosis oc-
curred and nuclear fragmentation was witnessed in
selenite-treated cells. Last, we discovered that cyto-
chrome C and AIF were released from the mitochondriato the cytoplasm, which suggested that selenite-induced
apoptosis in HL60 cells might be associated with the
mitochondrial apoptotic pathway. Cell cycle-related pro-
teins that were consistently altered with microtubule dy-
namics could regulate Bcl-2 family members, which
were located in the mitochondria. Therefore, we specu-
lated that selenite inhibited HL60 cell growth through
its effects on microtubules.
Several reports suggested that microtubule-interfering
drugs affected cell cycle distribution by regulating the
activity of CDKs and, therefore, altering protein phos-
phorylation at different cell cycle phases [11]. Mcl-1, a
Bcl-2 family member, is regulated by the Cyclin B1/
CDK1 complex and is linked to the mitochondrial apop-
totic pathway by binding and inhibiting pro-apoptotic
proteins [12,30,31]. Our current study proved that selen-
ite could induce cell cycle arrest and remarkable altera-
tions of Cyclin B1 and Mcl-1 levels in HL60 cells
through its effect on microtubule depolymerization.
Interestingly, a combination treatment of Colchicine and
selenite in Jurkat cells up-regulated Cyclin B1 and
down-regulated Mcl-1. The observations in Jurkat cells
also supported the relationship between microtubule de-
struction and alterations in Cyclin B1 and Mcl-1 after
selenite exposure. Cyclin B1 is necessary for the activity
Figure 5 Selenite had inhibitory effects on a HL60 xenograft tumor model. 4-week-old mice were divided into two groups randomly and
each group was marked and put into its own box. The two groups lived in the same context and were fed with the same food and water. Then
HL60 cells were given subcutaneously. After 1 week and tumors were detectable, PBS and selenite(1.5 mg/kg/day) were given to the control and
selenite-treated group every two days respectively. After each group was injected for 3 weeks, nude mice were sacrificed for analysis. (A) Tumor
weight decreased after selenite exposure. *P < 0.05. (B) Selenite caused nuclear pyknosis in tumor cells. This experiment was repeated at least 3
times. (C) Spleen weight decreased after selenite exposure. *P < 0.05. (D) Immunohistochemical staining indicated CD33 positive leukemia cells in
spleen were decreased after selenite treated. Scale bar represented 100 μm. This experiment was repeated at least 3 times. (E) Selenite induced
microtubule depolymerization in tumor cells. Soluble and insoluble-tubulin fractions were separated as indicated above and detected by western
blotting. This experiment was repeated at least 3 times. (F) Selenite had similar effects on the regulation of Cyclin B1 and Mcl-1 as it did in vitro.
This experiment was repeated at least 3 times. (G) In situ labeling of apoptotic tumor cells using the TUNEL assay indicated the appearance of
apoptotic cells after selenite treatment. Scale bar represented 100 μm. This experiment was repeated at least 3 times. (H) Immunohistochemical
staining indicated that alterations in Cyclin B1 and Mcl-1 levels were similar to those in vitro. Scale bar represented 25 μm. This experiment was
repeated at least 3 times
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[32-36]. We observed that Cyclin B1 interacted with
CDK1. Furthermore, either siRNA interference of Cyclin
B1 or inhibition of the CDK1/Cyclin B1 complex with
Roscovitine rescued the decrease of Mcl-1. Further in-
vestigation confirmed the protective role of Mcl-1 on
HL60 cells and suggested that the growth inhibitory
effects of selenite might be associated with the down-
regulation of Mcl-1. Finally, a combination of siRNA tar-
geting Mcl-1 and selenite treatment caused a higher
apoptotic ratio than selenite treatment alone. These
results supported our conclusion that selenite alteredmicrotubule assembly and inhibited HL60 cell growth
through cell cycle arrest and decrease in Mcl-1 levels.
The above-described experiments indicated that selen-
ite altered microtubule assembly and induced cell cycle
arrest in HL60 cells. To identify the therapeutic activity
of selenite in vivo, we established a HL60-cell-bearing
nude mice model. Experiments in vivo showed that sel-
enite inhibited tumor growth and induced nucleus
pyknosis. Furthermore, we also found that selenite depo-
lymerized microtubules in vivo. Additional experiments
demonstrated that alterations of Cyclin B1 and Mcl-1
levels in the nude mice model were similar to those
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demonstrated in vitro were also active at the tissue level.
Conclusions
In conclusion, the microtubule destruction that was
induced by selenite stimulated the apoptotic pathway by
up-regulating Cyclin B1, which interacted with CDK1
and destabilized the anti-apoptotic protein Mcl-1. We
also found that sodium selenite had therapeutic func-
tions in a HL60-cell-bearing nude mice model through
its microtubule destruction effects. Importantly, this in-
vestigation explored the effects of selenite on apoptosis
in a distinct way.
Materials and methods
Chemicals and antibodies
Roscovitin, anti-β-Tubulin (2-28-33) and anti-β-Actin
(AC-15) antibodies were obtained from Sigma-Aldrich.
Anti-Cyclin B1 and anti-Mcl-1 antibodies, which were
used for western blotting, were obtained from Cell Sig-
naling Technology. For immunohistochemical staining,
an anti-Cyclin B1 antibody was purchased from Excell,
an-anti CD33 antibody was purchased from BIOSS and
an anti-Mcl-1 antibody was purchased from Santa Cruz.
The Cdc2 (1/Cdk1/Cdc2) antibody was purchased from
BD Biosciences Pharmingen. HRP-conjugated anti-mouse
and anti-rabbit antibodies were purchased from ZSGB-
BIO. A FITC-conjugated anti-mouse antibody was pur-
chased from Jackson.
Cell culture
HL60 and Jurkat cells were grown in RPMI 1640
medium containing 10% advanced fetal bovine serum,
100 units/mL penicillin and 100 units/mL streptomycin
and incubated in a humidified, 5% CO2 incubator that
was set at 37°C.
Indirect immunofluorescence microscopy
HL60 cells (8 × 105 total) were harvested. The cells were
transferred to slides, fixed in 4% paraformaldehyde and
permeabilized using 0.1% Triton X-100. After the slides
were blocked with 2% BSA, the cells were incubated
with β-tubulin antibody overnight at 4°C. After washing
with PBS three times, the cells were incubated with
FITC-conjugated secondary antibody for 60 min at room
temperature. After a second round of washing, the cells
were stained with DAPI for approximately 5 min, and
the slides were washed three times and mounted in anti-
fading medium. Images were visualized using a Zeiss
microscope (Carl Zeiss, Jena, Germany).
Western blotting
Approximately 1 × 106 cells were collected for each
treatment. After washing with ice-cold PBS, the cellswere resuspended in RIPA lysis buffer (20 nM Tris, pH
7.5; 1 mM EDTA; 1 mM EGTA; 150 mM NaCl; 1% Tri-
ton X-100; 2.5 mM sodium pyrophosphate; 1 mM β-
glycerolphosphate; 1 mM Na3VO4; 1 mM PMSF; and
1 μg/mL leupeptin) and were submitted to ultrasonica-
tion on ice. The lysates were centrifuged at 12,000 × g
for 20 min at 4°C, and equal amounts of proteins were
separated by SDS-PAGE. The proteins on the PAGE gel
were then transferred to a nitrocellulose membrane.
After being blocked with 5% non-fat milk, the mem-
branes were washed with TBST and incubated overnight
with primary antibody at 4°C. After being washed three
times with TBST, the membranes were incubated with a
HRP-conjugated secondary antibody for approximately
1 h at room temperature. Subsequently, the membranes
were washed another three times and probed with
supersignal chemiluminescent substrate.Immunoprecipitation
Cells (1 × 107) were harvested and washed twice with
ice-cold PBS. The pellets were resuspended in RIPA buf-
fer and lysed on ice for 30 min. Subsequently, the lysates
were centrifuged at 12,000 × g for 20 min at 4°C. A suit-
able amount of cdc2 antibody was added to the protein
lysate (200 μg) and rotated overnight at 4°C, while the
remaining protein was used as input. Protein A +G was
added, and the mixture was rotated for another 3 h at 4°C;
then, the samples were washed with RIPA buffer three
times. Finally, the beads were resuspended in 3 × SDS
loading buffer and boiled for 10 min. After a short
centrifugation step, the supernatant was collected.siRNA interference
siRNAs targeting Cyclin B1 (50-CCAAACCTTTGTAGT
GAAT-30), Mcl-1 (50-GGACTGGCTAGTTAAACAA-30)
and negative controls for each sequence were synthe-
sized by GenePharma. Approximately 1 × 107 cells were
collected and washed with Opti-MEM medium (Gibco).
Then, the cells were transfected with 200 nM siRNA
and RNAiMAX in Opti-MEM. After transfection for ap-
proximately 12 h, the cells were treated with sodium sel-
enite for 24 h.Detection of cell cycle distribution
Approximately 1 × 106 cells were collected and fixed in
70% ethanol overnight at 4°C. Each sample was centri-
fuged at 1,000 × g for 10 min at room temperature and
washed with ice-cold PBS. Subsequently, the cells were
incubated with 50 μg/ml RNase in PBS for 30 min at 37°C.
After adding PI to the cells at a final concentration of
50 μg/mL, we detected the absorption at 620 nm by flow
cytometry.
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The cells (1 × 106) were harvested and washed twice
with ice-cold PBS. Subsequently, the cells were stained
with AnnexinV-FITC in binding buffer in the dark for
15 min. After being centrifuged at 1,000 × g for 10 min,
the cells were resuspended in binding buffer containing
PI. Finally, the apoptotic ratio was determined by an
Accuri C6 flow cytometry. We calculated the apoptotic
ratio by calculating the sum of Annexin V+/PI- cells’
ratio and Annexin V+/PI+ cells’ ratio.
The effect of sodium selenite on the viability of HL60
cells
HL60 cells were seeded into a 96-well plate at a concentra-
tion of 40,000 cells per well. After treatment with varying
concentrations of sodium selenite for 24 h, cell viability
was assessed using CCK-8 kits (Dojindo Molecular Tech-
nologies, Tokyo, Japan).
The in vivo microtubule polymerization assay
An established method was modified and used to separ-
ate insoluble tubulin from soluble tubulin [30]. Approxi-
mately 2 × 106 cells were collected and washed twice.
The cells were then resuspended in hypotonic buffer at
37°C for 5 min. After centrifugation at 14,000 × g for
10 min at 25°C, the supernatants, which contained sol-
uble tubulin, were collected, and the pellets containing
insoluble tubulin were resuspended in RIPA buffer and
subjected to ultrasonication on ice. The lysates were
centrifuged at 12,000 × g for 10 min at 4°C, and the
supernatants were collected.
Xenograft tumor model
At the beginning of the experiment, 4-week-old female
mice were chosen and divided into control or selenite-
treated group randomly. Each group was marked and
put into its own box. The two groups lived in the same
context and were fed with the same food and water.
Leukemia HL60 cells were inoculated subcutaneously
into female nude mice. After tumors were palpable, an
intraperitoneal injection of sodium selenite dissolved in
PBS was given to each mouse every 2 days (1.5 mg/kg/
day) for 3 weeks, and the control group was treated with
PBS for the same period time. At the end of the experi-
ment, the mice were sacrificed, and the tumors and
spleens were rapidly removed and weighed. The Declar-
ation of Helsinki and the guide for Laboratory Animal
Care and Use were maintained.
Immunohistochemical staining
The slides were deparaffinized in xylene and dehydrated
with decreasing concentrations of ethanol. After the
slides were washed with running water for 2 min, en-
dogenous peroxidase was blocked with 3% peroxide thatwas dissolved in methanol. Subsequently, the slides were
immersed in boiled sodium citrate for antigen retrieval,
and after being washed three times with 0.01 M PBS for
5 min, the slides were incubated with either anti-Mcl-1
or anti-Cyclin B1 antibody overnight at 4°C. The slides
were incubated with secondary antibody at room
temperature for 3 h, treated with DAB, stained with
Mayer’s hematoxylin for 2 min and washed with running
water. Slides were then dehydrated with increasing con-
centrations of ethanol and clarified with xylene. Finally,
the slides were mounted with medium.
HE staining
After dehydration with decreasing concentrations of
ethanol as described above, the slides were stained with
Harriss hematoxylin for 15 min and washed for 3 min.
Then, the slides were immersed in 1% hydrochloric acid
dissolved in 75% ethanol for 30 s. Before dehydration,
the slides were stained with eosin for 10 min. Finally, the
slides were clarified with xylene and mounted with
medium.
TUNEL assay
A FragEL™ DNA Fragmentation Detection Kit was pur-
chased from MERCK. The slides were deparaffinized in
xylene and dehydrated with decreasing concentrations of
ethanol. After washing with 1 × TBS for 2 min, the slides
were incubated with 20 μg/ml proteinase K for 20 min
at room temperature. The slides were then washed with
1 × TBS and incubated with 1 × TdT buffer for approxi-
mately 30 min at room temperature. Subsequently, the
slides were incubated with 57 μl of mix buffer and 3 μl
of TdT enzyme for 60 min at 37°C. After being washed
three times with 1 × TBS, the slides were mounted with
medium.
Statistical analysis
The values were represented as mean ± SEM. Two-tailed
students’ t-tests were used for two groups comparison
analysis, and P < 0.05 was considered to be significant.
The bar charts were used to reflect the alterations of ex-
perimental data [18,24,37,38].
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